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ABSTRACT
A novel method to efficiently generate unmarked
in-frame gene deletions in Rhodococcus equi was
developed, exploiting the cytotoxic effect of
5-fluorocytosine (5-FC) by the action of cytosine
deaminase (CD) and uracil phosphoribosyltransfer-
ase (UPRT) enzymes. The opportunistic, intracellular
pathogen R. equi is resistant to high concentrations
of 5-FC. Introduction of Escherichia coli genes
encoding CD and UPRT conferred conditional
lethality to R. equi cells incubated with 5-FC.
To exemplify the use of the codA::upp cassette as
counter-selectable marker, an unmarked in-frame
gene deletion mutant of R. equi was constructed.
The supA and supB genes, part of a putative cho-
lesterol catabolic gene cluster, were efficiently
deleted from the R. equi wild-type genome. Pheno-
typic analysis of the generated "supAB mutant
confirmed that supAB are essential for growth of
R. equi on cholesterol. Macrophage survival assays
revealed that the "supAB mutant is able to
survive and proliferate in macrophages comparable
to wild type. Thus, cholesterol metabolism does
not appear to be essential for macrophage
survival of R. equi. The CD-UPRT based 5-FC
counter-selection may become a useful asset in
the generation of unmarked in-frame gene deletions
in other actinobacteria as well, as actinobacteria
generally appear to be 5-FC resistant and 5-FU
sensitive.
INTRODUCTION
An important molecular tool in functional genomics stu-
dies is the targeted inactivation of any gene of interest.
Ideally, unmarked gene deletions are constructed using a
positive selection step for the rare second recombination
event. The sacB gene of Bacillus subtilis is one of the most
widely used suicide genes, conferring sucrose sensitivity
mostly in Gram-negative bacteria (1,2). Previously, we
reported the use of sacB counter-selection to eﬃciently
generate unmarked gene deletions in Rhodococcus erythro-
polis (3). This method subsequently has been applied in
other Rhodococcus species (4–6). Sucrose sensitivity by
sacB has also been reported for other mycolic acid con-
taining actinobacteria, i.e. Corynebacterium glutamicum
and Mycobacterium sp. (7). Despite considerable eﬀorts,
we have been unable to apply sacB as a counter-selectable
marker in Rhodococcus equi, due to a lack of sucrose sen-
sitivity. Similar observations have been reported for
Streptomyces lividans (7). The sacB counter-selection
system generally is not applicable to other Gram-positive
bacteria, like B. subtilis.I nB. subtilis, mazF, encoding
a toxin, has been used as a suicide marker to generate
unmarked gene deletion mutants (8). This method relies
on the availability of a tightly regulated, inducible pro-
moter, limiting applicability in bacteria with less devel-
oped molecular toolboxes. The use of alternative suicide
genes have been reported as well, e.g. glkA, pyrF, upp and
rpsL (9–12). A major drawback of these markers, how-
ever, is that they only function in glkA, pyrF, upp or
strA null mutants, respectively, necessitating the construc-
tion, or availability, of a null mutant for every strain to be
mutated. A PCR-targeted gene replacement strategy has
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ability of ordered genomic libraries to eﬃciently generate
mutants (13). This method, however, requires a labo-
rious extra round of mutagenesis to remove the resist-
ance marker integrated into the genome to generate
unmarked mutants. Recently, a simpliﬁed method for
marker removal in actinomycetes using Flp recombinase
has been described (14).
Cytosine deaminase (CD, EC 3.5.4.5) and uracil phos-
phoribosyltransferase (UPRT, EC 2.4.2.9) are enzymes
involved in the pyrimidine salvage pathway, converting
cytosine via uracil into dUMP. CD activity has been
found in certain prokaryotes and lower eukaryotes. The
genes encoding these activities in Escherichia coli, codA
and upp, respectively, have been cloned and characterized
(15,16). Interestingly, microorganisms expressing CD con-
vert the innocuous cytosine analog 5-ﬂuorocytosine
(5-FC) into 5-ﬂuorouracil (5-FU), a highly toxic com-
pound lethal to living cells. The cytotoxicity is largely
exerted following UPRT mediated conversion of 5-FU
into 5-ﬂuoro-dUMP, which irreversibly inactivates thymi-
dylate synthase inhibiting both RNA and DNA synthesis
(17). Heterologous expression of E. coli codA was shown
to confer 5-FC sensitivity to mammalian cells, ordinarily
not producing CD (18). Concomitant expression of E. coli
CD and UPRT as a fusion protein, encoded by codA::upp,
was shown to further enhance the 5-FC cytotoxicity (19).
A recent study on pyrimidine salvage in Streptomyces spe-
cies indicated a lack of CD activity but sensitivity towards
5-FU (20). Some other actinobacteria, like Rhodococcus
species, were also shown to be 5-FU sensitive (21,22).
Most Nocardia species and certain Mycobacterium strains,
however, were 5-FU resistant, while other mycobacteria
strains were highly 5-FU sensitive (21).
R. equi is a facultative intracellular pathogen that causes
fatal pyogranulomatous bronchopneumonia in young
foals. It is also an emerging opportunistic pathogen of
immuno-compromised humans, particularly HIV infected
patients (23,24). In addition to its pathogenic life-style, R.
equi is a common soil-dwelling microorganism capable of
rapid growth in soil and manure, using plant and animal
sterols as sole carbon and energy sources (25,26).
Knowledge on sterol metabolism in R. equi is extremely
limited. So far, only the gene encoding the proposed ﬁrst
step in cholesterol degradation, cholesterol oxidase
(choE), has been identiﬁed and inactivated in R. equi
(27,28). A cholesterol catabolic gene cluster has been
identiﬁed in the closely related Rhodococcus jostii RHA1
(6,29). This cluster also encodes a putative cholesterol
uptake system, designated mce4 operon. ‘Mammalian
cell entry’ (mce) genes are critical virulence factors of the
intracellular pathogen Mycobacterium tuberculosis (30)
and, interestingly, mce1
 and mce4
 strains of M. tuber-
culosis H37Rv showed attenuated survival in mice (31).
The supAB genes are part of the mce4 operon and may
encode the permease subunits of the cholesterol uptake
system (6). The supAB and mce4 genes were shown to
be essential for growth of R. jostii RHA1 on cholesterol
(6). Pandey and Sassetti (32) recently conﬁrmed that
cholesterol is used as a carbon and energy source by
M. tuberculosis H37Rv, and that the mce4 cluster in
H37Rv is essential for growth on cholesterol.
The R. equi strain 103S genome sequence recently has
become available (http://www.sanger.ac.uk/Projects/
R_equi/). Proper genome annotation and identiﬁcation
of pathogenicity genes requires simple methods for gene
deletion mutagenesis. A method for the isolation of gene
deletion mutants of R. equi by the double homologous
recombination strategy was ﬁrst reported by Navas et al.
(27). An improved method, using lacZ as counter-
selectable marker, was subsequently reported by Jain
et al. (33). These methods, however, often involve screen-
ing and handling of large numbers of colonies to select for
the rare second recombination event (34,35). Here we
show that introduction of the codA::upp cassette confers
5-FC sensitivity to R. equi allowing positive selection of
the targeted gene deletion mutants. A simple and eﬃcient
procedure to generate unmarked in-frame gene deletions
in R. equi is reported, exempliﬁed by the construction and
characterization of a supAB mutant.
MATERIALS AND METHODS
Culture media and growth conditions forR. equistrain RE1
Virulent R. equi wild type strain RE1 was isolated from a
foal with pyogranulomatous pneumonia in September
2007 in The Netherlands. R. equi strains were grown at
308C (200r.p.m.) in Luria-Bertani (LB) medium or
mineral acetate medium (MM-Ac). MM-Ac contained
K2HPO4 (4.65g/l), NaH2PO4H2O (1.5g/l), sodium-
acetate (2g/l), NH4Cl (3g/l), MgSO47H2O (1g/l), thia-
mine (40mg/l, ﬁlter sterile) and Vishniac stock solution
(1ml/l). Vishniac stock solution was prepared as follows
[modiﬁed from (36)]: EDTA (10g/l) and ZnSO47H2O
(4.4g/l) were dissolved in distilled water (pH 8 using
2M KOH). Then, CaCl22H2O (1.47g/l), MnCl27
H2O (1g/l), FeSO47H2O (1g/l), (NH4)6 Mo7O244H 2O
(0.22g/l), CuSO45H2O (0.315g/l) and CoCl26H 2O
(0.32g/l) were added in that order at pH 6 and ﬁnally
stored at pH 4. For growth on solid media Bacto-agar
(15g/l) was added. 5-Fluorocytosine (Sigma-Aldrich
Chemie, Zwijndrecht, The Netherlands) and 5-ﬂuorouracil
(Sigma-Aldrich) stock solutions (10mg/ml) were prepared
in distilled water, dissolved by heating to 508C, ﬁlter-
sterilized and added to autoclaved media.
For growth on cholesterol, R. equi strains were inocu-
lated in 25ml MM-Ac liquid medium and grown for 24h
at 200r.p.m. and 308C. The pre-culture (0.5ml) was used
to inoculate 50ml of MM medium containing 0.5g/l cho-
lesterol (Sigma-Aldrich) as sole carbon and energy source
which had been ﬁnely dispersed by sonication. Regular
turbidity (OD600nm) measurements of cholesterol grown
cultures were not possible due to high background of
the cholesterol suspension. Protein content of the culture
was used as a measure for biomass formation and was
determined as follows. A sample (0.5ml) of the culture
was pelleted by centrifugation (5min at 12000g) and thor-
oughly resuspended in 0.1ml Bacterial Protein Extraction
Reagent (B-PER, Pierce, PerBio Science Nederland B.V.,
Etten-Leur, The Netherlands). Then, 0.4ml distilled water
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at room temperature for 5–10min. An aliquot of 160ml
was mixed with 640ml of distilled water and 200mlo f
protein assay reagent (BioRad) was added. Protein con-
tent of the sample was determined using bovine serum
albumin (BSA) as a standard as described by the
manufacturer.
Cloning, PCR andchromosomal DNA isolation
E. coli DH5a was used as host for all cloning procedures.
Restriction enzymes were obtained from Fermentas
GmbH (St Leon-Rot, Germany). PCR was performed in
a reaction mixture (25ml) consisting of Tris–HCl (10mM,
pH 8), 10High-Fidelity polymerase buﬀer (Fermentas),
dNTPs (0.2mM), DMSO (2%), PCR primers (10ng/ml
each, Table 1) and High-Fidelity polymerase enzyme
(1–2U, Fermentas). For colony PCR, cell material was
mixed with 100ml of chloroform and 100mlo f1 0 m M
Tris–HCl pH 8, vortexed vigorously and centrifuged
(2min at 14000g). A sample of the upper water phase
(1ml) was subsequently used as template for PCR. Chro-
mosomal DNA of R. equi cell cultures was isolated using
the GenElute Bacterial Genomics DNA Kit (Sigma-
Aldrich) according to the instructions of the manufacturer.
Electrotransformation of R. equistrain RE1
R. equi strain RE1 cells were transformed by electropora-
tion essentially as described (27). Brieﬂy, cell cultures were
grown in 50ml LB at 308C until OD600 reached 0.8–1.0.
The cells were pelleted (20min at 4500g) and washed
twice with 10% ice-cold glycerol. Pelleted cells were
re-suspended in 0.5–1ml ice-cold 10% glycerol and
200ml aliquots were put on ice. MilliQ-eluted plasmid
DNA (5–10ml; GenElute Plasmid Miniprep Kit, Sigma-
Aldrich) was added to 200ml cells in 2mm gapped cuv-
ettes. Electroporation was performed with a single pulse of
12.5kV/cm, 1000 and 25mF. Electroporated cells were
gently mixed with 1ml LB medium and allowed to recover
for 2h at 378C and 200r.p.m. Aliquots (200ml) were
plated onto LB agar medium containing apramycin
(50mg/ml; Duchefa Biochemie, Haarlem, The Nether-
lands). Transformants appeared after 2–3 days of incuba-
tion at 308C. The transformation eﬃciency for
non-replicative plasmids integrating via homologous
recombination was  10 transformants/mg plasmid DNA.
5-Fluorocytosine positive selection in R. equi
R. equi transformants were inoculated in LB liquid
medium (25ml) and grown overnight (20–24h) at 308C
and 200r.p.m. 5-FC selection was performed by plating
100ml aliquots of a dilution series (10
1 to 10
3 in MM-Ac
medium) of the grown culture onto MM-Ac agar plates
supplemented with 5-FC (100mg/ml). Dilution of the cul-
ture prior to plating was crucial for eﬀective 5-FC selec-
tion. 5-FC resistant colonies appeared after 2–3 days of
incubation at 308C.
Construction ofplasmids pSET-Pkan-codA,
pSET-Pkan-codAupp andpSelAct
The aphII promoter region was ampliﬁed from pRESQ
(37) using PCR primers Pkan-F and Pkan-E5-R
(Table 1). The obtained PCR product of 367bp was
blunt-ligated into EcoRV digested pBluescript(II)KS
(Stratagene), resulting in pBs-Pkan. A SalI/NotI restric-
tion released a 431bp fragment comprising the aphII pro-
moter which was then cloned into SalI/NotI digested
pORF-codA::upp (InvivoGen, San Diego, USA), yielding
plasmid pORF-Pkan-codAupp. The Pkan-codA::upp
cassette was subsequently isolated from pORF-Pkan-
codAupp as a 2.4kb SmaI/NheI fragment and ligated
into EcoRV/XbaI digested pSET152 resulting in plasmid
pSET-Pkan-codAupp (Figure 2). The Pkan-codA cassette
(1733bp) was ampliﬁed from pSET-Pkan-codAupp using
primers Pkan-F and codA-R2 (Table 1) and ligated into
EcoRV digested pSET152, resulting in pSET-Pkan-codA
(Figure 2). Suicide plasmid pSelAct (Figure 3) was con-
structed by ligating a 2.4kb Klenow-treated EcoRI/NheI
fragment of pORF-Pkan-codAupp into SspI digested
pBs-Apra-ori dephosphoryated with alkaline phospha-
tase. Plasmid pBs-Apra-ori was constructed from
pBluescript(II)KS in which the bla cassette was removed
with BspHI, followed by Klenow treatment and replaced
by an apramycin-oriT cassette obtained as a 1.3kb XbaI
fragment (Klenow treated) from pIJ773 (13).
Macrophagesurvival test
The human monocyte cell line U937 (38) was used to test
for survival of R. equi strains. The monocytes were grown
in RPMI 1640 (Invitrogen)+NaHCO3 (1g/l)+sodium
pyruvate (0.11g/l)+glucose medium (4.5g/l) (RPMI
1640 medium), buﬀered with 10mM HEPES (Hopax
ﬁne chemicals, Taiwan) and supplemented with penicillin
(200IU/ml), streptomycin (200IU/ml) and 10% fetal
bovine serum (FBS). The cells were grown in suspension
at 378C and 5% CO2. For the macrophage survival assay,
monocytes were grown for several days as described
above. The culture medium was replaced with fresh cul-
ture medium and the cells were activated overnight with
phorbol 12-myristate 13-acetate (60ng/ml, PMA, Sigma-
Aldrich) to induce their diﬀerentiation to macrophages.
The diﬀerentiated cells were spun down (5min at 200g)
and the pellet was re-suspended in fresh, antibiotic free
RPMI 1640 medium with 10% FBS. For each strain to
be tested, a tube containing 10ml of a cell suspension
(10
6cells/ml) was inoculated with R. equi, pre-grown in
nutrient broth (Difco, Detroit, MI., USA) at 378C, at a
multiplicity of infection (MOI) of approximately 10 bac-
teria per macrophage. The bacteria were incubated with
the macrophages for 1h at 378C and 5% CO2. The
medium was replaced with 10ml RPMI 1640 medium sup-
plemented with 10% FBS and 100mg/ml gentamycin and
incubated again for 1h to kill any extra-cellular bacteria.
The macrophages (with internalized R. equi) were spun
down (5min at 200g) and the pellet was re-suspended in
40ml RPMI 1640 medium, buﬀered with 10mM HEPES
and supplemented with 10% FBS and gentamycin
(10mg/ml). This suspension was divided over four culture
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After 4, 28, 52 and 76h the macrophages (one culture
bottle per strain) were spun down (5min at 200g) and
the pellet washed twice in 1ml antibiotic free RPMI
1640 medium. Finally the pellet was lysed with 1%
Triton X-100 (Sigma-Aldrich) in 0.01M phosphate buf-
fered saline, followed by live count determination (plate
counting).
Culture mediaand growth conditions for5-FC selection
inactinobacteria
Actinobacterial strains (Table 2) were grown until late
exponential phase as shaken liquid cultures in complex
medium at 308C, except for Amycolatopsis methanolica
and Mycobacterium smegmatis which were grown at
378C. Tryptic Soy Broth (TSB) was used for Corynebacter-
ium glutamicum, Arthrobacter globiformis, Amycolatopsis
orientalis, A. methanolica and M. smegmatis. TSB supple-
mented with 2.5% NaCl was used for Salinospora tropica,
and YEME:TSB (1:1) (39) for all Streptomyces strains
and Saccharopolyspora erythrea. LB was used for R. equi
and Rhodococcus rhodochrous and LBP (3) was used for
R. erythropolis and R. jostii. Minimal regeneration medium
(MRM) consisted of K2SO4 (0.25g/l), (NH4)2SO4 (2g/l),
MgCl26H20 (0.6g/l), 2-[(hydroxyl-1, 1-bis (hydroxy-
methyl)ethyl)amino] ethanesulfonic acid; TES (5.73g/l)
and trace elements (39). Sucrose (10.3% w/v) and L-proline
(0.3% w/v) were added to MRM medium for Streptomyces
strains, but omitted for all other strains. Glucose (20mM)
was used as carbon and energy source, except for all
Rhodococcus strains which were grown in the presence of
acetate (2g/l). Autoclaved MRM was supplemented with
KH2PO4 (0.1g/l), CaCl22H20 (3g/l) and NaOH (0.28g/l).
For agar plates 2% granulated agar was added. Filter-
sterilized thiamine (40mg/ml) was added to autoclaved
MRM medium for growth of Rhodococcus strains. 5-FC
and 5-FU were freshly prepared as 10mg/ml stocks in
distilled water, dissolved by heating to 508C and added
to autoclaved medium.
RESULTS AND DISCUSSION
CD-UPRT mediated 5-fluorocytosine sensitivity
ofR. equi strainRE1
An obvious prerequisite for the applicability of a 5-FC
based conditionally lethal positive selection system is nat-
ural resistance of R. equi strain RE1 towards 5-FC. To test
this, R. equi RE1 was streaked onto acetate mineral
(MM-Ac) agar plates supplemented with 5-FC or 5-FU
and incubated for 3 days at 308C. Examination of the
plates revealed that R. equi was resistant to high concen-
trations of 5-FC (100mg/ml), but highly sensitive to a
lower concentration of 5-FU (50mg/ml), indicating the
feasibility of developing a 5-FC based positive selection
system for R. equi (Figure 1). Next, we examined whether
expression of the E. coli genes codA and upp in R. equi
would confer sensitivity to 5-FC and thus could act as a
suicide marker. The integrative E. coli-Streptomyces shut-
tle vector pSET152 provided a stable and convenient vehi-
cle to introduce codA or a functional codA::upp fusion into
Figure 1. Introduction of E. coli codA::upp cassette, encoding CD and
UPRT, confers 5-FC sensitivity to R. equi strain RE1. Panels show wild
type strain RE1, recombinant strain RE1 containing pSET152, recom-
binant strain RE1 containing plasmid pSET-codA::upp streaked on
mineral acetate agar (MM-Ac) containing (A) no addition, (B) 5-FC
(100mg/ml) or (C) 5-FU (50mg/ml) and on (D) LB agar containing
5-FC (100mg/ml).
Figure 2. The pSET152 derived integrative plasmids used to introduce
the (A) codA or (B) codA::upp cassette into R. equi RE1, expressed
under control of the aphII kanamycin resistance cassette promoter
(PaphII). The apramycin resistance cassette (aac(3)IV), the
Streptomyces PhiC31 integrase gene (int) and the RP4 origin of transfer
(oriT) are also indicated.
Figure 3. Schematic representation of the non-replicative plasmid
pSelAct used to generate unmarked in-frame gene deletions in R. equi
RE1. Restriction sites indicated are unique.
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the kanamycin resistance cassette (Pkan) was used to
drive expression of codA or codA::upp, respectively. The
two resulting integrative plasmids, pSET-Pkan-codA
and pSET-Pkan-codAupp (Figure 2), were mobilized sepa-
rately by electroporation to R. equi RE1. Transformants
harboring either pSET-Pkan-codA or pSET-Pkan-
codAupp were streaked onto MM-Ac agar plates
(Figure 1A), MM-Ac agar plates supplemented with
100mg/ml 5-FC (Figure 1B), or MM-Ac agar plates sup-
plemented with 50mg/ml 5-FU (Figure 1C) and incubated
for 3 days at 308C. The presence of the codA::upp cassette
rendered R. equi sensitive to 5-FC, whereas expression of
codA alone did not result in 5-FC sensitivity (Figure 1B).
Growth of the R. equistrain carrying thecodA::upp cassette
under nonselective conditions was similar to that of wild
type (Figure 1A), indicating that expression is condition-
ally lethal and not detrimental to cells when 5-FC is
omitted from the medium. Importantly, no 5-FC selection
was observed when complex agar media (LB) was used
(Figure 1D). This may be due to repression of the pyrimi-
dine salvage pathway aﬀecting 5-FC uptake.
To enable the generation of unmarked in-frame gene
deletions in R. equi using CD-UPRT based 5-FC condi-
tional lethality, we next developed a non-replicative sui-
cide vector designated pSelAct (Figure 3; see Materials
and Methods section). Vector pSelAct is a small (5.6kb)
conjugative plasmid based on pBlueScript(II)KS, harbor-
ing the aac(3)IV cassette for apramycin resistance that can
be used both in E. coli and R. equi. The vector contains a
MCS with several unique restriction sites for cloning
ﬂanking regions of the gene of interest using lacZ depen-
dent blue-white screening in E. coli.
Unmarked in-frame gene deletion of supAB inR. equi
A BLAST search with the supA (ro04696), supB (ro04697)
and mce4 (ro04698-ro04703) genes of R. jostii RHA1,
predicted to encode the cholesterol uptake machinery
(6), revealed that these genes and their apparent operonic
organization were highly conserved in the R. equi 103S
genome (Figure 4; http://www.sanger.ac.uk/Projects/
R_equi/). Highest amino acid identities were observed
for SupA (94%) and SupB (89%), whereas the mce4
encoded proteins Mce4A-Mce4F showed lower identities
(57–71%) (Figure 4).
The supA and supB genes are the ﬁrst two genes of the
mce4 operon, and may encode the cholesterol permease
subunits (Figure 4). To demonstrate a speciﬁc role of
supAB in cholesterol catabolism, we aimed for their selec-
tive inactivation, without aﬀecting expression of the
downstream genes. This prompted us to develop the
unmarked in-frame gene deletion system for R. equi
based on counter-selection with 5-FC. The upstream and
downstream ﬂanking regions (1.5kb) of the supAB genes
were ampliﬁed by PCR and ligated into pSelAct generat-
ing pSelAct-supAB (Figure 4; Table 1 for primers). This
construct was used to generate a supAB mutant, by
reducing the wild type supA (765nt) and supB (852nt)
genes, encompassing 1637bp, to a single in-frame open-
reading-frame of 231bp, encoding the ﬁrst 20 amino acid
of SupA and the last 54 amino acids of SupB, separated by
a6b pSmaI restriction site. The ﬁrst and last part of supA
and supB, respectively, were left intact to ensure proper
expression of downstream genes in the mce4 operon.
Introduction of plasmid pSelAct-supAB into R. equi
RE1, selecting for apramycin resistance, resulted in 29
transformants of which four were selected and grown non-
selectively overnight for 20h in LB medium (i.e. lacking
apramycin and 5-FC). Aliquots (100ml) of the overnight
cultures were plated in 10
1 to 10
3 dilutions onto MM-
Ac agar plates supplemented with 100mg/ml 5-FC and
incubated for 3 days at 308C. Conﬂuent growth on 5-FC
selection plates was obtained for one of the transformants.
Conceivably, the codA::upp suicide cassette had been inac-
tivated in this transformant by spontaneous mutation or
transposon insertion, as has been reported to occur during
sacB counter-selection (3,42). Typically, >10
2 colonies
grew on the 10
2 plate from which 50 colonies were replica
picked onto LB agar with and without apramycin to select
for 5-FC
R/Apra
S colonies. The frequency of 5-FC
R/Apra
S
colonies amongst the other three transformants varied
between 70–90%, indicating that the suicide cassette had
been inactivated in 10–30% of the 5-FC
R/Apra
S colonies.
For one transformant, eighteen 5-FC
R/Apra
S colonies
were checked by colony PCR for the presence of the
mutant supAB genotype using PCR with oligonucleo-
tides 6 and 7 amplifying the supAB genes (Table 1,
Figure 4). Two of the eighteen FC
R/Apra
S colonies gave
a PCR product of the expected size (231bp) and were
selected for further characterization. Genomic DNA was
isolated from these two supAB mutants and subjected to
PCR analysis of the supAB locus and the up- and down-
stream ﬂanking regions of supAB (Figure 5, see Table 1 for
oligonucleotides used). This conﬁrmed the presence of a
genuine supAB gene deletion in both cases and revealed no
aberrant genomic rearrangements at the supAB locus
(Figure 5). One mutant strain was chosen, designated R.
equi RE1supAB, and was used for further
characterization.
Phenotypical analysis and functionalcomplementation
ofR. equi RE1"supAB mutant
R. equi RE1 wild type and the RE1supAB mutant strain
were grown in MM-Ac liquid medium and used to inocu-
late MM-cholesterol liquid medium. The RE1supAB
mutant was completely blocked in growth on cholesterol
as sole carbon and energy source (Figure 6). Growth on
acetate or the steroid substrate 4-androstene-3,17-dione
(AD) was unaﬀected and comparable to the wild type
strain (data not shown). This indicated that supAB are
essential for cholesterol catabolism, probably acting as
the permease subunits of the cholesterol ABC transporter.
These results are fully consistent with the phenotype of the
supAB mutant of strain RHA1 (6).
To ensure that the growth deﬁciency of the
RE1supAB mutant was solely due to deletion of the
supAB genes, a 3163-bp DNA fragment carrying
the wild-type supAB genes was introduced by electropora-
tion into the RE1supAB mutant. The DNA fragment
was obtained by PCR on strain RE1 wild type DNA
PAGE 5 OF 10 Nucleic Acids Research, 2008, Vol. 36,No. 22 e151Figure 4. (A) Schematic overview of the molecular organization of the mce4 gene clusters in R. jostii RHA1 and R. equi 103S. Percentages indicate
amino acid sequence identities between the Mce4 proteins of R. jostii RHA1 and R. equi RE1. (B) Construction of mutagenic plasmid pSelAct-
supAB used to generate an unmarked supAB gene deletion mutant of R. equi RE1. Small black arrows with numbers indicate the PCR oligonu-
cleotides used in this study (Table 1) and the site of their annealing. (C) Molecular organization of the mce4 locus of R. equi RE1 following
integration of pSelAct-supAB by single homologous recombination, and second homologous recombinant event after 5-FC counter-selection,
resulting in supAB gene deletion.
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cloned into the integrative plasmid SET152, resulting in
pSET-supAB. The cholesterol growth negative phenotype
of the RE1supAB mutant harboring pSET-supAB was
fully complemented, restoring growth on cholesterol to
levels comparable to the wild type (Figure 6). We conclude
that the supAB deletion did not exert any polar eﬀects on
the expression of other genes in the mce4 operon.
These data show that we have developed a novel, simple
and eﬃcient method to generate unmarked in-frame gene
deletions in R. equi, based on 5-FC lethality in the pre-
sence of the E. coli codA::upp fusion gene.
Deletion of supAB doesnot affectR. equiRE1 survival
in macrophages
Intracellular survival and proliferation of the R. equi
RE1supAB mutant in the human monocyte cell line
U937 was compared to those of wild type strain RE1
(Figure 7). The avirulent, plasmid free strain R. equi
103
 (43) was included as a negative control for macro-
phage survival (Figure 7). The results revealed that the
RE1supAB mutant is able to survive and proliferate in
macrophages comparable to the wild-type parent strain
RE1. By contrast, the avirulent strain 103
 failed to pro-
liferate, resulting in reduced numbers of intracellular
Table 1. Oligonucleotides used in this study
No PCR amplicon Size (bp) Oligonucleotide sequence (nr.)
1 Upstream region supAB (deletion construct) 1592 supABequiUP-F ATCGCGAGGTCAGCTTGGAG (1)
supABequiUP-R CCCGGGCGCCGACATCGCGAAGAATC (2)
2 Downstream region supAB (deletion construct) 1470 supABequiDOWN-F CCCGGGCTCATCCACACCTACTACGG (3)
supABequiDOWN-R ACTAGTGAGCTGCTGAATCTGAACTGG (4)
3 Upstream region supAB (conﬁrmation deletion mutant) 1786 (wt: 3192) supABequiContrUP-F CGGGAGTGCGTAGATGAGTGCA (5)
supABequiContr-R TTATCCCGAAAGGTTGAAGTTG (6)
4 Downstream region supAB (conﬁrmation deletion mutant) 1570 (wt: 2976) supABequiContr-F GTGGTCGACCTCCTCGAGGTAC (7)
supABequiContrDOWN-R GGACTTGAGCCCGGAGGCATCG (8)
5 supAB genes (conﬁrmation deletion mutant) 231 (wt: 1637) supABequiContr-F GTGGTCGACCTCCTCGAGGTAC (7)
supABequiContr-R TTATCCCGAAAGGTTGAAGTTG (6)
6 supAB genes (complementation supAB mutant) 3163 supABequiUP-F ATCGCGAGGTCAGCTTGGAG (1)
supABequiContr-R TTATCCCGAAAGGTTGAAGTTG (6)
7 aphII promoter region 367 Pkan-F AGCTTCACGCTGCCGCAAGCACT
Pkan-E5-R GATATCATGCGAAACGATCCTCATCCTG
8 Pkan-codA cassette 1733 Pkan-F AGCTTCACGCTGCCGCAAGCACT
codA-R2 GTCAACGTTTGTAATCGATGGCTTCT
9 vapA 408 vapA-F GCAGCAGTGCGATTCTCAATAG (9)
vapA-R TAACTCCACCGGACTGGATATG (10)
Primer numbering used in the text is shown between brackets following the nucleotide sequence.
Figure 6. Growth curves in mineral medium supplemented with choles-
terol (0.5g/l) of R. equi RE1 wild-type (ﬁlled diamond), RE1 supAB
mutant strain (ﬁlled square), RE1 supAB+pSET-supAB complemen-
ted strain (ﬁlled triangle), and RE1 supAB+pSET152 control strain
(x). Protein content (mg/l) of the culture was used as a measure for
biomass formation. The data represent the averages for two indepen-
dent experiments.
Figure 5. PCR analysis of wild type R. equi strain RE1 (wt) and two supAB gene deletion mutants of R. equi strain RE1 (1 and 2). Panels show
ampliﬁcation of (I) the supAB locus [6+7], (II) the upstream region of supAB [5+6], (III) the downstream region of supAB [7+8], (IV) the vapA
virulence gene [9+10]. The oligonucleotides used are mentioned between brackets and described in Table 1 and/or Figure 4.
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cholesterol metabolism is not essential for macrophage
survival of R. equi RE1 and suggest that cholesterol
metabolism is not important for virulence of R. equi
RE1 in vivo. These observations are consistent with the
ﬁnding that ChoE is not important in the virulence of
R. equi (28).
Actinobacteria aregenerally 5-FC resistant
The CD-UPRT based 5-FC selection could also be a
useful asset in the generation of unmarked in-frame gene
deletions in other actinobacteria. To examine whether
CD-UPRT selection potentially is an eﬀective counter-
selectable marker in this family of microorganisms, we
tested the sensitivity of several actinobacteria towards
5-FC and 5-FU. A wide selection of actinobacterial strains
were grown in complex medium until late exponential/
early stationary phase and plated in 10-fold dilutions
onto mineral selection media containing increasing con-
centrations of 5-FC or 5-FU (Table 2). The tested strains
generally were resistant to high concentrations of 5-FC
(100mg/ml), but highly sensitive to lower concentrations
of 5-FU (20–50mg/ml), indicating the feasibility of devel-
oping a 5-FC based positive selection system for other
actinobacteria.
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Table 2. Growth of actinobacteria on MRM mineral agar media supplemented with diﬀerent concentrations of 5-FC or 5-FU
Strain 5-FC (mg/ml) 5-FU (mg/ml) Reference/origin
0 20 50 100 20 50 100
Amycolatopsis methanolica NCIB11946 ++ + – – – (44)
Amycolatopsis orientalis ATCC 19795 ++ ++ + + ATCC
Arthrobacter globiformis DSM 20124 ++ ++ + + – – – DSMZ
Corynebacterium glutamicum ATCC 13032 ++ + – – ATCC
Mycobacterium smegmatis mc
2155 ++ + – – – (45)
Rhodococcus rhodochrous DSM 43269 ++ ++ ++ ++ + – – DSMZ
Rhodococcus erythropolis SQ1 ++ ++ ++ ++ – – – (46)
Rhodococcus jostii RHA1 ++ ++ ++ ++ +  – M. Fukuda, Nagaoka (Japan)
Rhodococcus equi RE1 ++ ++ ++ ++ + – – Schering-Plough, Netherlands
Salinospora tropica ++ ++ ++ ++ DSMZ
Saccharopolyspora erythraea ++ ++ ++ ++ – – – DSMZ
Streptomyces albus J1074 ++ ++ ++ ++ – – – (47)
Streptomyces avermitilis MA-4680 ++ ++ ++ ++ ++ ++ ++ ATCC (ATCC 31267)
Streptomyces coelicolor M145 ++ ++ ++ ++ – – – (39)
Streptomyces griseus DSM40236 ++ ++ ++ ++ – – – DSMZ
Streptomyces lividans TK23 ++ ++ ++ ++ – – – (39)
Streptomyces scabies ISP5078 ++ ++ ++ + – – – Wellington, Warwick (UK)
Streptomyces tendae Tu ¨ 901/8c ++ ++ ++ + + – – (48)
Symbols indicate growth (++), moderate growth (+), slight/minor growth () or no growth (–).
ATCC, American Type Culture Collection; DSMZ, Deutsche Sammlung von Mikroorganismen und Zellkulturen.
Figure 7. Survival and proliferation of R. equi strains in the human
monocyte cell line U937. Macrophage cell suspensions were infected
with wild type virulent strain R. equi RE1 (ﬁlled diamond), mutant
strain R. equi RE1supAB (ﬁlled square) and non-virulent (control)
strain R. equi 103
 (ﬁlled triangle). Following a 1-h incubation to
allow phagocytosis, cells were washed and treated with gentamycin to
kill remaining extra-cellular bacteria. The numbers of intracellular
bacteria were determined by plate counts following macrophage lysis.
The data represent the averages for two independent experiments.
Plate counts were carried out in duplicate.
e151 Nucleic Acids Research, 2008, Vol. 36, No. 22 PAGE 8 OF10REFERENCES
1. Ried,J.L. and Collmer,A. (1987) An nptI-sacB-sacR cartridge for
constructing directed, unmarked mutations in gram-negative
bacteria by marker exchange-eviction mutagenesis. Gene,
57, 239–246.
2. Reyrat,J.M., Pelicic,V., Gicquel,B. and Rappuoli,R. (1998)
Counterselectable markers: untapped tools for bacterial genetics
and pathogenesis. Infect. Immun., 66, 4011–4017.
3. Van der Geize,R., Hessels,G.I., Van Gerwen,R., Van der Meijden,P.
and Dijkhuizen,L. (2001) Unmarked gene deletion mutagenesis of
kstD, encoding 3-ketosteroid 
1-dehydrogenase, in Rhodococcus
erythropolis SQ1 using sacB as counter-selectable marker. FEMS
Microbiol. Lett., 205, 197–202.
4. Nga,D.P., Altenbuchner,J. and Heiss,G.S. (2004) NpdR, a repressor
involved in 2,4,6-trinitrophenol degradation in Rhodococcus opacus
HL PM-1. J. Bacteriol., 186, 98–103.
5. Sharp,J.O., Sales,C.M., LeBlanc,J.C., Liu,J., Wood,T.K.,
Eltis,L.D., Mohn,W.W. and Alvarez-Cohen,L. (2007) An inducible
propane monooxygenase is responsible for N-nitrosodimethylamine
degradation by Rhodococcus sp. strain RHAI. Appl. Environ.
Microbiol., 73, 6930–6938.
6. Van der Geize,R., Yam,K., Heuser,T., Wilbrink,M.H., Hara,H.,
Anderton,M.C., Sim,E., Dijkhuizen,L., Davies,J.E., Mohn,W.W.
et al. (2007) A gene cluster encoding cholesterol catabolism in a
soil actinomycete provides insight into Mycobacterium tuberculosis
survival in macrophages. Proc. Natl Acad. Sci. USA,
104, 1947–1952.
7. Ja ¨ ger,W., Scha ¨ fer,A., Pu ¨ hler,A., Labes,G. and Wohlleben,W. (1992)
Expression of the Bacillus subtilis sacB gene leads to sucrose
sensitivity in the gram-positive bacterium Corynebacterium
glutamicum but not in Streptomyces lividans. J. Bacteriol.,
174, 5462–5465.
8. Zhang,X.Z., Yan,X., Cui,Z.L., Hong,Q. and Li,S.P. (2006) mazF,a
novel counter-selectable marker for unmarked chromosomal
manipulation in Bacillus subtilis. Nucleic Acids Res., 34, e71.
9. Van Wezel,G.P. and Bibb,M.J. (1996) A novel plasmid vector that
uses the glucose kinase gene (glkA) for the positive selection of
stable gene disruptants in Streptomyces. Gene, 182, 229–230.
10. Hosted,T.J. and Baltz,R.H. (1997) Use of rpsL for dominance
selection and gene replacement in Streptomyces roseosporus. J.
Bacteriol., 179, 180–186.
11. Knipfer,N., Seth,A. and Shrader,T.E. (1997) Unmarked gene inte-
gration into the chromosome of Mycobacterium smegmatis via
precise replacement of the pyrF gene. Plasmid, 37, 129–140.
12. Fabret,C., Ehrlich,S.D. and Noirot,P. (2002) A new mutation
delivery system for genome-scale approaches in Bacillus subtilis.
Mol. Microbiol., 46, 25–36.
13. Gust,B., Challis,G.L., Fowler,K., Kieser,T. and Chater,K.F. (2003)
PCR-targeted Streptomyces gene replacement identiﬁes a protein
domain needed for biosynthesis of the sesquiterpene soil odor
geosmin. Proc. Natl Acad. Sci. USA, 100, 1541–1546.
14. Fedoryshyn,M., Petzke,L., Welle,E., Bechthold,A. and
Luzhetskyy,A. (2008) Marker removal from actinomycetes genome
using Flp recombinase. Gene, 419, 43–47.
15. Andersen,L., Kilstrup,M. and Neuhard,J. (1989) Pyrimidine, purine
and nitrogen control of cytosine deaminase synthesis in Escherichia
coli K 12. Involvement of the glnLG and purR genes in the regu-
lation of codA expression. Arch. Microbiol., 152, 115–118.
16. Danielsen,S., Kilstrup,M., Barilla,K., Jochimsen,B. and Neuhard,J.
(1992) Characterization of the Escherichia coli codBA operon
encoding cytosine permease and cytosine deaminase. Mol.
Microbiol., 6, 1335–1344.
17. Heidelberger,C., Danenberg,P.V. and Moran,R.G. (1983)
Fluorinated pyrimidines and their nucleosides. Adv. Enzymol. Relat.
Areas Mol. Biol., 54, 58–119.
18. Mullen,C., Kilstrup,M. and Blaese,R.M. (1992) Transfer of the
bacterial gene for cytosine deaminase to mammalian cells confers
lethal sensitivity to 5-ﬂuorocytosine: A negative selection system.
Proc. Natl Acad. Sci. USA, 89, 33–37.
19. Tiraby,M., Cazaux,C., Baron,M., Drocourt,D., Reynes,J.P. and
Tiraby,G. (1998) Concomitant expression of E. coli cytosine
deaminase and uracil phosphoribosyltransferase improves the
cytotoxicity of 5-ﬂuorocytosine. . FEMS Microbiol. Lett.,
167, 41–49.
20. Hughes,L.E., Beck,D.A. and O’Donovan,G.A. (2005)
Pathways of pyrimidine salvage in Streptomyces. Curr. Microbiol.,
50, 8–10.
21. Tsukamura,M. (1981) Diﬀerentiation between genera
Mycobacterium, Rhodococcus and Nocardia by susceptibility to
5-ﬂuorouracil. J. Gen. Microbiol., 125, 205–208.
22. Tsukamura,M., Komatsuzaki,C., Sakai,R., Kaneda,K., Kudo,T.
and Seino,A. (1988) Mesenteric lymphadenitis of swine caused by
Rhodococcus sputi. J. Clin. Microbiol., 26, 155–157.
23. Prescott,J.F. (1991) Rhodococcus equi: an animal and human
pathogen. Clin. Microbiol. Rev., 4, 20–34.
24. Meijer,W.G. and Prescott,J.F. (2004) Rhodococcus equi. Vet. Res.,
35, 383–396.
25. Ahmad,S., Roy,P.K., Basu,S.K. and Johri,B.N. (1993) Cholesterol
side-chain cleavage by immobilized cells of Rhodococcus equi
DSM89-133. Indian J. Exp. Biol., 31, 319–322.
26. Murohisa,T. and Iida,M. (1993) Some new intermediates in micro-
bial side chain degradation of b-sitosterol. J. Ferment. Bioeng.,
76, 174–177.
27. Navas,J., Gonza ´ lez-Zorn,B., Ladro ´ n,N., Garrido,P. and Va ´ zquez-
Boland,J.A. (2001) Identiﬁcation and mutagenesis by allelic
exchange of choE, encoding a cholesterol oxidase from the
intracellular pathogen Rhodococcus equi. J. Bacteriol.,
183, 4796–4805.
28. Pei,Y., Dupont,C., Sydor,T., Haas,A. and Prescott,J.F. (2006)
Cholesterol oxidase (ChoE) is not important in the virulence of
Rhodococcus equi. Vet. Microbiol., 118, 240–246.
29. McLeod,M.P., Warren,R.L., Hsiao,W.W., Araki,N., Myhre,M.,
Fernandes,C., Miyazawa,D., Wong,W., Lillquist,A.L., Wang,D.
et al. (2006) The complete genome of Rhodococcus sp. RHA1
provides insights into a catabolic powerhouse. Proc. Natl Acad. Sci.
USA, 103, 15582–15587.
30. Rengarajan,J., Bloom,B.R. and Rubin,E.J. (2005) Genome-wide
requirements for Mycobacterium tuberculosis adaptation and
survival in macrophages. Proc. Natl Acad. Sci. USA,
102, 8327–8332.
31. Joshi,S.M., Pandey,A.K., Capite,N., Fortune,S.M., Rubin,E.J. and
Sassetti,C.M. (2006) Characterization of mycobacterial virulence
genes through genetic interaction mapping. Proc. Natl Acad. Sci.
USA, 103, 11760–11765.
32. Pandey,A.K. and Sassetti,C.M. (2008) Mycobacterial persistence
requires the utilization of host cholesterol. Proc. Natl Acad. Sci.
USA, 105, 4376–4380.
33. Jain,S., Bloom,B.R. and Hondalus,M.K. (2003) Deletion of
vapA encoding Virulence Associated Protein A attenuates the
intracellular actinomycete Rhodococcus equi. Mol. Microbiol.,
50, 115–128.
34. Pei,Y., Nicholson,V., Woods,K. and Prescott,J.F. (2007)
Immunization by intrabronchial administration to 1-week-old foals
of an unmarked double gene disruption strain of Rhodococcus equi
strain 103+. Vet. Microbiol., 125, 100–110.
35. Pei,Y., Parreira,V., Nicholson,V.M. and Prescott,J.F. (2007)
Mutation and virulence assessment of chromosomal genes of
Rhodococcus equi 103. Can. J. Vet. Res., 71, 1–7.
36. Vishniac,W. and Santer,M. (1957) The thiobacilli. Bacteriol. Rev.,
21, 195–213.
37. Van der Geize,R., Hessels,G.I., Van Gerwen,R., Van der Meijden,P.
and Dijkhuizen,L. (2002) Molecular and functional characterization
of kshA and kshB, encoding two components of 3-ketosteroid
9a-hydroxylase, a class IA monooxygenase, in Rhodococcus
erythropolis SQ1. Mol. Microbiol., 45, 1007–1018.
38. Sundstrom,C. and Nilsson,K. (1976) Establishment and character-
ization of a human histiocytic lymphoma cell line (U937). Int. J.
Cancer, 17, 565–577.
39. Kieser,T., Bibb,M.J., Buttner,M.J., Chater,K.F. and
Hopwood,D.A. (2000) Practical Streptomyces Genetics, John Innes
Foundation, Norwich, UK.
40. Bierman,M., Logan,R., O’Brien,K., Seno,E.T., Rao,R.N. and
Schoner,B.E. (1992) Plasmid cloning vectors for the conjugal
transfer of DNA from Escherichia coli to Streptomyces spp. Gene,
116, 43–49.
PAGE 9 OF 10 Nucleic Acids Research, 2008, Vol. 36,No. 22 e15141. Hong,Y. and Hondalus,M.K. (2008) Site-speciﬁc integration
of Streptomyces PhiC31 integrase-based vectors in the
chromosome of Rhodococcus equi. FEMS Microbiol. Lett.,
287, 63–68.
42. Ja ¨ ger,W., Scha ¨ fer,A., Kalinowski,J. and Pu ¨ hler,A. (1995) Isolation
of insertion elements from gram-positive Brevibacterium,
Corynebacterium and Rhodococcus strains using the Bacillus subtilis
sacB gene as a positive selection marker. FEMS Microbiol. Lett.,
126, 1–6.
43. Takai,S., Hines,S.A., Sekizaki,T., Nicholson,V.M., Alperin,D.A.,
Osaki,M., Takamatsu,D., Nakamura,M., Suzuki,K., Ogino,N. et al.
(2000) DNA sequence and comparison of virulence plasmids from
Rhodococcus equi ATCC33701 and 103. Infect. Immun.,
68, 6840–6847.
44. De Boer,L., Dijkhuizen,L., Grobben,G., Goodfellow,M.,
Stackebrandt,E., Parlett,J.H., Whitehead,D. and Witt,D. (1990)
Amycolatopsis methanolica sp. nov., a facultative methylotrophic
actinomycete. Int. J. Sys. Bacteriol., 40, 194–204.
45. Snapper,S.B., Melton,R.E., Mustafa,S., Kieser,T. and Jacobs,W.R.
Jr. (1990) Isolation and characterization of eﬃcient plasmid trans-
formation mutants of Mycobacterium smegmatis. Mol. Microbiol.,
4, 1911–1919.
46. Quan,S. and Dabbs,E.R. (1993) Nocardioform arsenic resistance
plasmid characterization and improved Rhodococcus cloning
vectors. Plasmid, 29, 74–79.
47. Chater,K.F. and Wilde,L.C. (1980) Streptomyces albus G mutants
defective in the SalGI restriction-modiﬁcation system. J. Gen.
Microbiol., 116, 323–334.
48. Richter,M., Willey,J.M., Su ¨ ssmuth,R., Jung,G. and Fiedler,H.-P.
(1998) Streptofactin, a novel biosurfactant with aerial mycelium
inducing activity from Streptomyces tendae T{ 901/8c. FEMS
Microbiol. Lett., 163, 165–171.
e151 Nucleic Acids Research, 2008, Vol. 36, No. 22 PAGE 10 OF10